Skip to content
Search

Latest Stories

Inventor gifts tablet press to the University students

The equipment (Tablet Press Machine) can be used in pharmaceutical studies as well as metallurgy and 3D printing

Dr Michael Gamlen, the inventor of Gamlen instruments presents a tablet press machine to the students at the School of Pharmacy on 16 October.


The equipment not only solves the challenge of producing lab-scale tablets under precise conditions but also offers valuable insights into material compaction properties.

It is also known as a powder compaction analyser which has been given on loan to the University of Sunderland for five years.

2023pr127pic4 scaled The powder compaction analyser was gifted to University of Sunderland students' by Dr Michael Gamlen. Credit: David Wood

Dr Gamlen talks about the machine and how pharmacy students will benefit, saying: “It allows you to make tablets under tightly controlled conditions and enables you to make accurate comparisons between different materials and processes.

“The students will be able to easily see the impact of the tablet compaction conditions on tablet properties. This is very important to understand when developing new tablet formulations and manufacturing products.”

Dr Gamlen collaborated with Fette Compacting, a provider of integrated solutions for industrial tablet production in the pharmaceutical industry at the beginning of the year.

The technology has been adopted by major companies including Pfizer, GSK, Novartis and Novo Nordisk.

It can be used in pharmaceutical studies as well as metallurgy and 3D printing.

As a former student, Dr Gamlen specialised in Pharmaceutical Engineering and conducted a project focused on tablet granulation and compaction – and as a result, has been studying tabletting ever since.

2023pr127pic3 scaled Dr Michael Gamlen with his wife Alice Noon. Credit: David Wood

Later, he and his wife, Alice Noon, returned to the City campus to gift the tablet press to the university students.

The machine is used by various leading universities in the UK including Imperial College London, Rutgers University, MIT and Copenhagen University, confirmed Dr Gamlen.

“I wanted to make it available to the students at my academic birthplace in Sunderland,” he added.

“I was impressed by the University’s new facilities during my recent visit. To see modern labs and lecture theatres was very refreshing and I am sure it all provides a great learning experience for the students.

“I very much enjoyed my time in Sunderland and it’s great to be able to give something back,” said Dr Gamlen.

Dr Paul Carter, practising Community Pharmacist and Senior Lecturer in Pharmaceutical Sciences at the University, said: “Our School of Pharmacy has a very strong alumni association, and we are very grateful to Dr Gamlen for providing education and research opportunities for both undergraduates and postgraduate students.

“Our continued relationship means both staff and students are benefiting greatly from Dr Gamlen’s considerable experience and skills.

“We are always open to strengthening links with our alumni members; this is a great example of how the alumni network can support and help us progress in our teaching and research.”

In 2011, Dr Gamlen founded his own company – Gamlen Tableting Limited – and created the world’s first computer-controlled benchtop tablet press, which would lead to the conception of the Gamlen Powder Compaction Analyser; a groundbreaking instrument for the study of the entire compaction process of powdered materials.

More For You

Skill mix and independent prescribing: The essential ingredients for pharmacy’s future

L-R: Nicola Stockmann, Robert Townsend, Atul Patel, and Amerjit Singh

Skill mix and independent prescribing – Key to driving pharmacy forward

“The workforce is your greatest asset,” said Nicola Stockmann, president of the Association of Pharmacy Technicians UK (APTUK).

Speaking at the recent Pharmacy Business Conference, she emphasised that investing in the entire pharmacy team, including pharmacy technicians and assistants, is essential for sustainable growth.

Keep ReadingShow less
How community pharmacies can safely and profitably deliver high-quality NHS and private services

L-R: Baba Akomolafe, Rachna Chhatralia, Patricia Tigenoah-Ojo, and Raj Matharu

How community pharmacies are optimising services for a sustainable future

“Community pharmacy has come to a point where we have to change ourselves,” said Raj Matharu, CEO at Community Pharmacy South East London, and Superintendent Pharmacist of Westchem Pharmacy, as he opened a panel discussion at the recent Pharmacy Business Conference.

The 'Optimising Service Opportunities' session centred on how community pharmacies can safely and profitably deliver high-quality NHS and private services, while ensuring an excellent patient experience.

Keep ReadingShow less
How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less